Amit Biswas - Dr Reddys President

RDY -- USA Stock  

USD 38.01  1.10  2.81%

  President
Dr. Amit Biswas serves as an Executive Vice President and Head Integrated Product Development of Dr. Reddy Laboratories Ltd July 2011. Amit is a Ph.D and Masters in Polymer Science from Case Western Reserve University, Ohio, USA and a Bachelor of Technology in Chemical Engineering from Indian Institute of Technology, Bombay.
Age: 56  President Since 2016  MBA    
91 40 4900 2900  http://www.drreddys.com

Management Efficiency

The company has Return on Asset of 5.42 % which means that on every $100 spent on asset it made $5.42 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.08 % implying that it generated $15.08 on every 100 dollars invested.
The company has 811.73M in debt with debt to equity (D/E) ratio of 23.5 . This implies that the company may be unable to create cash to meet all of its financial commitments. Dr Reddys Laboratories has Current Ratio of 1.85 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives

PRESIDENT Since

Louis YuPerrigo Company plc
2013
Reshma KewalramaniVertex Pharmaceuticals Incorpor
2018
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
2014
John WesolowskiPerrigo Company plc
2016
Michael PariniVertex Pharmaceuticals Incorpor
2017
Charles MilsteinVertex Pharmaceuticals Incorpor
2017
Jatin ShahPerrigo Company plc
2005
George YancopoulosRegeneron Pharmaceuticals
2016
Ronald JanishPerrigo Company plc
2015
Douglas McCorkleRegeneron Pharmaceuticals
2007
Roman TrawickiZoetis
2015
Peter PowchikRegeneron Pharmaceuticals
2006
Clinton LewisZoetis
2018
Jay MarkowitzRegeneron Pharmaceuticals
2017
Kristin PeckZoetis
2018
Paul SilvaVertex Pharmaceuticals Incorpor
2019
Catherine KnuppZoetis
2012
Ian SmithVertex Pharmaceuticals Incorpor
2017
Douglas BoothePerrigo Company plc
2013
Charles WagnerVertex Pharmaceuticals Incorpor
2019
Joseph LaRosaRegeneron Pharmaceuticals
2019

Entity Summary

Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. Reddys Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India. Dr Reddys operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 21966 people.Dr Reddys Laboratories Ltd (RDY) is traded on BATS Exchange in USA and employs 21,966 people.

Dr Reddys Laboratories Leadership Team

G Prasad, Co-Chairman of the Board, Chief Executive Officer, Managing Director
MARC KIKUCHI, Chief Executive Officer, North America Generics
Hans Hasler, Additional Independent Director
Leo Puri, Non-Executive Independent Director
Sandeep Poddar, Compliance Officer, Company Secretary
Satish Reddy, Co-Chairman of the Board
Kedar Upadhye, IR Contact Officer
Samiran Das, Executive Vice President Head - FTO and GGPM
Sauri Gudlavalleti, Global Head of Integrated Product Development Organization
YUGANDHAR PUVVALA, Global Head of Supply Chain
Amit Biswas, Executive Vice President - Integrated Product Development
Ravi Bhoothalingam, Non-Executive Independent Director
Alok Sonig, Senior Vice President & India Business Head (Generics)
Allan Oberman, Non-Executive Independent Director
J Ramachandran, Executive Vice President-Management Systems and Corporate Initiatives
Prasad Menon, Lead Non-Executive Independent Director
K Rao, Sr. Vice President & Head ? Chemical Technical Operations (CTO)
Abhijit Mukherjee, COO
Anil Namboodiripad, Global Head of Proprietary Products
Saumen Chakraborty, President, Chief Financial Officer and Global Head of ITBPE, Legal & Compliance and FMCRE
SANJAY SHARMA, Global Head of Manufacturing
Shikha Sharma, Non-Executive Independent Director
Sridar Iyengar, Non-Executive Independent Director
Ganadhish Kamat, Executive Vice President and Global Head-Quality
Sripada Chandrasekhar, President, Global Head of HR and Member of Management Council
Omkar Goswami, Non-Executive Independent Director
Erez Israeli, Chief Operating Officer and Global Head of Generics & PSAI
Kalpana Morparia, Non-Executive Independent Director
Bharat Doshi, Non-Executive Independent Director
J Moreau, Non-Executive Independent Director
Raymond Vre, Global Head of Biologics
Raghav Chari, Senior Vice President - Proprietary Products
Bruce Carter, Non-Executive Independent Director
Saunak Savla, IR Contact Officer
Ashok Ganguly, Non-Executive Independent Director
Umang Vohra, Executive Vice President Head - North America Generics
M Ramana, Chief Executive Officer, Branded Markets (India and Emerging Markets)
Cartikeya Reddy, Senior Vice President Head - Biologics
Anupam Puri, Non-Executive Independent Director
Archana Bhaskar, Chief Human Resource Officer
Deepak Sapra, Global Head of PSAI

Stock Performance Indicators

Current Sentiment - RDY

Dr Reddys Laboratories Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Dr Reddys Laboratories Ltd. What is your opinion about investing in Dr Reddys Laboratories Ltd? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

GOOG   
Purchased one share of
few hours ago
Traded for 1221.15
UGAZ   
Purchased over 100 shares of
few hours ago
Traded for 19.55
TWTR   
Purchased over 40 shares of
few hours ago
Traded for 43.23
JD   
Purchased over 60 shares of
few hours ago
Traded for 30.83
MDT   
Purchased few shares of
few hours ago
Traded for 111.18
Additionally take a look at Your Equity Center. Please also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Search macroaxis.com